The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

By Nancy Lapid (Reuters) -GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and Ozempic for weight loss and lowering blood sugar.

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst ...

India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

A phenotype-based profiling test can help predict whether a patient might respond better to one antiobesity medicine or ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

A survey reveals that while awareness of weight loss drugs is rising in India, a majority of citizens prefer non-medical methods due to concerns over side effects and safety. Experts advocate for a ...